Marcus Mall, University of Toronto

Research

Agonist Cftr Computational Chemistry Molecular Biology Slc26a9 Small Molecules Transporter

Latest funding

Investigating SLC26A9 as an alternative therapeutic target in cystic fibrosis
CIHR · 2025 · Principal investigator
$1,116,900

All 1 grants and awards

Investigating SLC26A9 as an alternative therapeutic target in cystic fibrosis

Principal investigatorCIHR2025Project Grant

Principal investigators: Strug, Lisa J; Mall, Marcus A

Keywords: Agonist; Cftr; Computational Chemistry; Molecular Biology; Slc26a9; Small Molecules; Transporter

$1,116,900

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2025

Subject: Prospective PhD student: Agonist Dear Professor Mall, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on agonist connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Investigating SLC26A9 as an alternative therapeutic target in cystic fibrosis" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]